Latest Articles
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - BioSpace
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial BioSpace
Published: June 2, 2025, 11:48 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - GlobeNewswire
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial GlobeNewswire
Published: June 2, 2025, 6:32 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo Finance
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo Finance
Published: June 2, 2025, 6:30 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo
Published: June 2, 2025, 6:30 p.m.
Trina Mansour, MD, highlights surgical strategies for managing endometriosis - Contemporary OB/GYN
Trina Mansour, MD, highlights surgical strategies for managing endometriosis Contemporary OB/GYN
Published: May 20, 2025, 9:14 p.m.
Endometrial aging is accompanied by H3K27ac and PGR loss - Nature
Endometrial aging is accompanied by H3K27ac and PGR loss Nature
Published: May 20, 2025, 6:07 p.m.
Megan Wasson, DO, on advancing endometriosis care through imaging, surgical precision, and mentorship - Contemporary OB/GYN
Megan Wasson, DO, on advancing endometriosis care through imaging, surgical precision, and mentorship Contemporary OB/GYN
Published: May 19, 2025, 7:58 p.m.
Multiomic insight into the involvement of cell aging related genes in the pathogenesis of endometriosis - Nature
Multiomic insight into the involvement of cell aging related genes in the pathogenesis of endometriosis Nature
Published: April 23, 2025, 9:58 a.m.
The value of multi-sequence magnetic resonance imaging and whole-tumor apparent diffusion coefficient histogram analysis in differentiating p53 abnormal from non-p53 abnormal endometrial carcinoma - Frontiers
The value of multi-sequence magnetic resonance imaging and whole-tumor apparent diffusion coefficient histogram analysis in differentiating p53 abnormal from non-p53 abnormal endometrial carcinoma Frontiers
Published: April 15, 2025, 2:55 p.m.
Aging: Weight training may slow, and help reverse cognitive decline - Medical News Today
Aging: Weight training may slow, and help reverse cognitive decline Medical News Today
Published: April 10, 2025, 2:48 p.m.
Link copied to clipboard!